Abstract

Pomalidomide: A new IMiD with remarkable activity in both multiple myeloma and myelofibrosis

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Thalidomide Therapy and Deep Venous Thrombosis in Multiple Myeloma
S Vincent Rajkumar
Mayo Clinic Proceedings | VOL. 80
S Vincent RajkumarS Vincent Rajkumar
01 Dec 2005
ASH 2009 meeting report—Top 10 clinically oriented abstracts in multiple myeloma
S Vincent Rajkumar ... Shaji Kumar
American Journal of Hematology | VOL. 85
S Vincent Rajkumar, et. al.S Vincent Rajkumar ... Shaji Kumar
03 Feb 2010
Myelofibrosis: Thalidomide Finds a New Disease
Richard T Silver
Mayo Clinic Proceedings | VOL. 79
Richard T SilverRichard T Silver
01 Jul 2004
Multiple Myeloma: New Options, New Challenges
Martha Q Lacy
Mayo Clinic Proceedings | VOL. 81
Martha Q LacyMartha Q Lacy
01 Jul 2006
View more papers

More From: American Journal of Hematology

Paper Title
Journal
Date
Author
A randomized double-blind pilot study to evaluate the efficacy, safety, and tolerability of intravenous iron versus oral iron for the treatment of restless legs syndrome in patients with iron deficiency anemia.
Richard Allen ... Huzefa Bahrain
American journal of hematology | VOL. 99
Richard Allen, et. al.Richard Allen ... Huzefa Bahrain
01 Jun 2024
-
-
American Journal of Hematology | VOL. 99
--
01 Jun 2024
Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Tamer Othman ... Matthew Mei
American journal of hematology | VOL. -
Tamer Othman, et. al.Tamer Othman ... Matthew Mei
28 May 2024
Outcomes following allogeneic hematopoietic cell transplantation relapse in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Tamer Othman ... Paul Koller
American journal of hematology | VOL. -
Tamer Othman, et. al.Tamer Othman ... Paul Koller
27 May 2024
View more papers